Beijing Baylx Biotechnology Co.
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- Undisclosed
Investors
- 4
About Beijing Baylx Biotechnology Co.
, Ltd. is a biotechnology manufacturer that focuses on the development of stem cell therapeutics for different diseases. The company participated in the formulation of quality management standards for stem cell preparations, and its products have received the Quality Management Certificate of Stem Cell Preparation. The company has multiple honors, including specialized, special, and new enterprises in Beijing, Zhongguancun Biomedical TOP10. Moreover, the company has obtained 2 clinical trial licenses issued by the State Drug Administration of China and 2 clinical trial licenses issued by the US Food and Drug Administration (FDA), and registered clinical trials are in progress. The company has two categories of stem cell therapeutic candidates product, Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC) for autoimmune diseases and engineered hUC-MSC for malignant diseases. The autoimmune diseases include Arthritis (RA), Crohn's disease (CD), liver disease, as well as advanced cancers. The hUC-MSC is from the human cord tissues. The advantages of hUC-MSC include the non-invasive procedure for the donor, proliferation, ex vivo scalability, and biological activities, which are better than MSC derived from other adult tissues.
Who invested in Beijing Baylx Biotechnology Co.
4 investors across 2 rounds
See all investors in Beijing Baylx Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Baylx Biotechnology Co.
Who invested in Beijing Baylx Biotechnology Co.?
Beijing Baylx Biotechnology Co. has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Baylx Biotechnology Co. raised?
Beijing Baylx Biotechnology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Baylx Biotechnology Co. last raise money?
Beijing Baylx Biotechnology Co.'s most recent round on record is a Series B, in Mar 2022.
What does Beijing Baylx Biotechnology Co. do?
Beijing Baylx Biotechnology Co. is a biotechnology company.
Where is Beijing Baylx Biotechnology Co. headquartered?
Beijing Baylx Biotechnology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Baylx Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Beijing Baylx Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Beijing Baylx Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.